AU6121000A - Pneumococcal surface protein combination vaccine - Google Patents

Pneumococcal surface protein combination vaccine Download PDF

Info

Publication number
AU6121000A
AU6121000A AU61210/00A AU6121000A AU6121000A AU 6121000 A AU6121000 A AU 6121000A AU 61210/00 A AU61210/00 A AU 61210/00A AU 6121000 A AU6121000 A AU 6121000A AU 6121000 A AU6121000 A AU 6121000A
Authority
AU
Australia
Prior art keywords
epitope
pspa
psaa
pspc
pneumococcal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU61210/00A
Other languages
English (en)
Inventor
Edwin Ades
David E. Briles
George M Carlone
Robert C. Huebner
Jacquelyn S. Sampson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Pasteur SA
UAB Research Foundation
Centers of Disease Control and Prevention CDC
Original Assignee
Aventis Pasteur SA
UAB Research Foundation
Centers of Disease Control and Prevention CDC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pasteur SA, UAB Research Foundation, Centers of Disease Control and Prevention CDC filed Critical Aventis Pasteur SA
Publication of AU6121000A publication Critical patent/AU6121000A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
    • C07K14/3156—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci from Streptococcus pneumoniae (Pneumococcus)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/543—Mucosal route intranasal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU61210/00A 1999-06-10 2000-06-09 Pneumococcal surface protein combination vaccine Abandoned AU6121000A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US13842299P 1999-06-10 1999-06-10
US60138422 1999-06-10
US58783300A 2000-06-06 2000-06-06
US09587833 2000-06-06
PCT/US2000/040176 WO2000076541A1 (en) 1999-06-10 2000-06-09 Pneumococcal surface protein combination vaccine

Publications (1)

Publication Number Publication Date
AU6121000A true AU6121000A (en) 2001-01-02

Family

ID=26836182

Family Applications (1)

Application Number Title Priority Date Filing Date
AU61210/00A Abandoned AU6121000A (en) 1999-06-10 2000-06-09 Pneumococcal surface protein combination vaccine

Country Status (7)

Country Link
EP (1) EP1189632A4 (https=)
JP (1) JP2003519089A (https=)
AU (1) AU6121000A (https=)
BR (1) BR0011478A (https=)
CA (1) CA2379327A1 (https=)
MX (1) MXPA01012721A (https=)
WO (1) WO2000076541A1 (https=)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7078042B2 (en) * 1995-09-15 2006-07-18 Uab Research Foundation Pneumococcal surface protein C (PspC), epitopic regions and strain selection thereof, and uses therefor
US20010016200A1 (en) 1998-04-23 2001-08-23 Briles David E. Pneumococcal surface protein C (PspC), epitopic regions and strain selection thereof, and uses therefor
GB0022742D0 (en) * 2000-09-15 2000-11-01 Smithkline Beecham Biolog Vaccine
EP1477802A1 (en) * 2003-05-16 2004-11-17 Erasmus Universiteit Rotterdam Method for selecting and producing vaccine components and vaccines based thereon
AU2007285775B2 (en) * 2006-08-17 2011-03-03 Sanofi Pasteur Ltd. Immunogenic PcpA polypeptides and uses thereof
RU2510281C2 (ru) * 2012-06-22 2014-03-27 Общество с ограниченной ответственностью "Эпитоп" (ООО "Эпитоп") ВАКЦИНА ПРОТИВ ПНЕВМОНИИ, ВЫЗЫВАЕМОЙ Streptococcus pneumoniae, НА ОСНОВЕ ГИБРИДНОГО БЕЛКА
GB201318170D0 (en) * 2013-10-14 2013-11-27 Univ Edinburgh Proteins with Diagnostic and Therapeutic Uses
KR101627285B1 (ko) * 2014-06-05 2016-06-07 한국생명공학연구원 ＰｓｐＡ를 유효성분으로 포함하는 퇴행성 뇌질환의 예방 또는 치료용 약학 조성물

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5854416A (en) * 1991-11-14 1998-12-29 The United States Of America As Represented By The Department Of Health And Human Services Streptococcus pneumoniae 37-KDA surface adhesin a protein and nucleic acids coding therefor
WO1994014318A1 (en) * 1992-12-24 1994-07-07 Medimmune, Inc. Method of protection against streptococcus pneumoniae with transformed mycobacteria
BR9908476A (pt) * 1998-03-02 2000-12-05 Us Health Peptìdeo, composição terapêutica, e, processo para conferir imunidade protetora a um paciente, contra a infecção de s. pneumoniae
JP2002516251A (ja) * 1998-04-23 2002-06-04 ユーエイビー リサーチ ファンデーション 肺炎球菌表面プロテインＣ（ＰｓｐＣ）のエピトープ領域およびその菌株選択、ならびにそのための使用法

Also Published As

Publication number Publication date
JP2003519089A (ja) 2003-06-17
MXPA01012721A (es) 2004-10-14
WO2000076541A1 (en) 2000-12-21
EP1189632A4 (en) 2002-08-21
BR0011478A (pt) 2002-03-19
CA2379327A1 (en) 2000-12-21
EP1189632A1 (en) 2002-03-27

Similar Documents

Publication Publication Date Title
AU726927B2 (en) Strain selection of pneumococcal surface proteins
AU770378B2 (en) Pneumococcal surface protein C(PspC), epitopic regions and strain selection thereof, and uses therefor
US7960535B2 (en) Recombinant lipidated PsaA protein, methods of preparation and use
CN103501809B (zh) 针对肺炎链球菌（Streptococcus Pneumoniae）的疫苗和组合物
JP2017160238A (ja) ストレプトコッカス・ニューモニエ（Ｓｔｒｅｐｔｏｃｏｃｃｕｓ ｐｎｅｕｍｏｎｉａｅ）に対する融合抗原ワクチンおよび組成物
EP0682950B1 (en) Mucosal administration of pneumococcal antigens
AU6121000A (en) Pneumococcal surface protein combination vaccine
US7078042B2 (en) Pneumococcal surface protein C (PspC), epitopic regions and strain selection thereof, and uses therefor
US6232116B1 (en) Oral administration of pneumococcal antigens
US7049419B2 (en) Pneumococcal surface protein C (PspC), epitopic regions and strain selection thereof, and uses therefor
RU2701733C1 (ru) Живая вакцина на основе штамма пробиотиков ENTEROCOCCUS FAECIUM L3 для профилактики инфекции, вызванной STREPTOCOCCUS PNEUMONIE
AU709368B2 (en) Oral administration of pneumococcal antigens
CN105131093A (zh) 一种肺炎链球菌蛋白抗原及其制备与应用
ES2382893T3 (es) Antígenos BVH-A2 y BVH-3 de streptococcus del grupo B
WO2026068728A1 (en) A klebsiella pneumoniae vaccine
WO2000076587A1 (en) Antibody-based treatment for streptococcus pneumoniae infection
HK1192166A (en) Vaccines and compositions against streptococcus pneumoniae